Literature DB >> 27752816

Perioperative hepatocyte growth factor (HGF) infusions improve hepatic regeneration following portal branch ligation (PBL) in rodents.

Christopher W Mangieri1,2, Jason C McCartt3, Matthew A Strode3, John E Lowry3, Prasad M Balakrishna3.   

Abstract

BACKGROUND: As hepatic surgery has become safer and more commonly performed, the extent of hepatic resections has increased. When there is not enough expected hepatic reserve to facilitate primary resection of hepatic tumors, a clinical adjunct to facilitating primary resection is portal vein embolization (PVE). PVE allows the hepatic remnant to increase to an appropriate size prior to resection via hepatocyte regeneration; however, PVE is not always successful in facilitating adequate regeneration. One of the strongest trophic factors for hepatocyte regeneration is hepatocyte growth factor (HGF). The purpose of this study was to improve hepatic regeneration with perioperative HGF infusions in an animal model that mimics PVE.
METHODS: Portal branch ligation (PBL) in rodents is equivalent to PVE in humans. We performed left-sided PBL in Sprague-Dawley rodents with the experimental group receiving perioperative HGF infusions. Baseline and postoperative liver volumetrics were obtained with CT scanning methods as performed in clinical practice. Baseline and postoperative liver functions were assessed via indocyanine green (ICG) elimination testing.
RESULTS: HGF infused rodents had statistically significant increase in all postoperative liver volumetrics. Most clinically relevant were increased right liver volumes (RLV), 14.10 versus 7.85 cm3 (p value 0.0001), and increased degree of hypertrophy (DH %), 159.23 versus 47.11 % (p value 0.0079). HGF infused rodents also had a quick return to baseline liver function, 2.38 days compared to 6.13 days (p value 0.0001).
CONCLUSION: Perioperative HGF infusions significantly increase hepatic regeneration following PBL in rodents. Perioperative HGF infusions following PVE are a possible adjunct to increase the amount of patients able to successfully undergo primary resection for hepatic tumors. Further basic science is warranted in examining the use of HGF infusions to increase hepatic regeneration and translating that basic science work to clinical practice.

Entities:  

Keywords:  Hepatic regeneration; Hepatocyte growth factor (HGF); Portal branch ligation (PBL)

Mesh:

Substances:

Year:  2016        PMID: 27752816     DOI: 10.1007/s00464-016-5288-9

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  27 in total

1.  Hepatocyte growth factor.

Authors:  G K Michalopoulos; R Zarnegav
Journal:  Hepatology       Date:  1992-01       Impact factor: 17.425

Review 2.  Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review.

Authors:  Y Yokoyama; M Nagino; Y Nimura
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

3.  Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy.

Authors:  H Lau; K Man; S T Fan; W C Yu; C M Lo; J Wong
Journal:  Br J Surg       Date:  1997-09       Impact factor: 6.939

4.  Hepatocyte growth factor supply accelerates compensatory hypertrophy caused by portal branch ligation in normal and jaundiced rats.

Authors:  T Kaido; A Yoshikawa; S Seto; S Yamaoka; M Sato; T Ishii; K Inoue; M Imamura
Journal:  J Surg Res       Date:  1999-07       Impact factor: 2.192

5.  Portal branch ligation with a continuous hepatocyte growth factor supply makes extensive hepatectomy possible in cirrhotic rats.

Authors:  T Kaido; A Yoshikawa; S Seto; S Yamaoka; M Sato; T Ishii; M Imamura
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

6.  Heparin-binding epidermal growth factor-like growth factor links hepatocyte priming with cell cycle progression during liver regeneration.

Authors:  Claudia Mitchell; Mary Nivison; Leslie F Jackson; Richard Fox; David C Lee; Jean S Campbell; Nelson Fausto
Journal:  J Biol Chem       Date:  2004-11-08       Impact factor: 5.157

7.  ICG pulse spectrophotometry for perioperative liver function in hepatectomy.

Authors:  Osamu Okochi; Tetsuya Kaneko; Hiroyuki Sugimoto; Soichiro Inoue; Shin Takeda; Akimasa Nakao
Journal:  J Surg Res       Date:  2002-03       Impact factor: 2.192

8.  Tumor necrosis factor primes hepatocytes for DNA replication in the rat.

Authors:  E M Webber; J Bruix; R H Pierce; N Fausto
Journal:  Hepatology       Date:  1998-11       Impact factor: 17.425

9.  Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA.

Authors:  W M Mars; R Zarnegar; G K Michalopoulos
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

10.  Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression.

Authors:  G Shiota; T C Wang; T Nakamura; E V Schmidt
Journal:  Hepatology       Date:  1994-04       Impact factor: 17.425

View more
  3 in total

Review 1.  Liver regeneration biology: Implications for liver tumour therapies.

Authors:  Christopher Hadjittofi; Michael Feretis; Jack Martin; Simon Harper; Emmanuel Huguet
Journal:  World J Clin Oncol       Date:  2021-12-24

2.  Single-Cell Transcriptomes Reveal Characteristic Features of Mouse Hepatocytes with Liver Cholestatic Injury.

Authors:  Na Chang; Lei Tian; Xiaofang Ji; Xuan Zhou; Lei Hou; Xinhao Zhao; Yuanru Yang; Lin Yang; Liying Li
Journal:  Cells       Date:  2019-09-11       Impact factor: 6.600

3.  Preparation of MED1(transcription mediator subunit) gene nanocarrier and its mechanism of action on liver cell regeneration in chronic acute liver failure.

Authors:  Jinwei Guo; Zhixiang Zhang; Jincan Zhu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.